WHO ICTRP trial
To evaluate the efficacy and safety of perampanel monotherapy in the treatment…
ChiCTR2300068059 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300068059 |
|---|---|
| Public title | To evaluate the efficacy and safety of perampanel monotherapy in the treatment of newly diagnosed children with focal epilepsy in China in a real-world setting |
| Scientific title | To evaluate the efficacy and safety of perampanel monotherapy in the treatment of newly diagnosed children with focal epilepsy in China in a real-world setting |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Focal epilepsy |
| Interventions | observation group:Pirentanil, once a day |
| Registration date | Feb 6, 2023 |
| Target size | observation group:210 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: